X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6567) 6567
Publication (566) 566
Book Chapter (38) 38
Book Review (38) 38
Dissertation (25) 25
Conference Proceeding (14) 14
Government Document (8) 8
Trade Publication Article (3) 3
Magazine Article (2) 2
Newspaper Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
osteoprotegerin (4394) 4394
humans (3590) 3590
index medicus (3111) 3111
animals (2287) 2287
female (2232) 2232
male (2107) 2107
mice (1439) 1439
osteoporosis (1394) 1394
middle aged (1361) 1361
rankl (1214) 1214
receptor activator (1145) 1145
osteoprotegerin - metabolism (1121) 1121
endocrinology & metabolism (1100) 1100
expression (1032) 1032
adult (1023) 1023
rank ligand - metabolism (1006) 1006
aged (999) 999
rank ligand (865) 865
bone (835) 835
osteoprotegerin - blood (814) 814
kappa-b ligand (788) 788
cells, cultured (783) 783
differentiation (763) 763
osteoprotegerin - genetics (760) 760
musculoskeletal diseases (713) 713
cells (694) 694
osteoclastogenesis (652) 652
rats (652) 652
gene expression (641) 641
osteoclast differentiation (635) 635
trance protein (621) 621
cell biology (619) 619
osteoclasts - metabolism (617) 617
receptor activator of nuclear factor-kappa b (617) 617
bone resorption (616) 616
opg (605) 605
analysis (592) 592
osteoblasts (569) 569
osteoblasts - metabolism (563) 563
in-vitro (562) 562
dentistry, oral surgery & medicine (560) 560
osteoclasts (558) 558
osteoprotegerin ligand (554) 554
inflammation (538) 538
bones (537) 537
cytokines (537) 537
postmenopausal women (527) 527
osteoclast (524) 524
rank ligand - genetics (523) 523
receptors, tumor necrosis factor (522) 522
dentistry (516) 516
ligand (516) 516
osteoclasts - drug effects (505) 505
bone density (498) 498
biochemistry & molecular biology (480) 480
biomarkers - blood (480) 480
osteoclasts - cytology (475) 475
risk factors (459) 459
medicine, research & experimental (446) 446
rheumatology (442) 442
bone and bones - metabolism (438) 438
oncology (434) 434
research (428) 428
bone-resorption (424) 424
orthopedics (423) 423
disease (422) 422
biocompatibility (400) 400
density (399) 399
enzyme-linked immunosorbent assay (398) 398
proteins (396) 396
apoptosis (384) 384
osteoblasts - drug effects (384) 384
ligands (380) 380
medicine & public health (367) 367
immunology (365) 365
physiological aspects (365) 365
signal transduction (365) 365
metabolism (364) 364
rank ligand - blood (362) 362
osteogenesis (359) 359
cell differentiation (352) 352
resorption (345) 345
bone loss (342) 342
rna, messenger - metabolism (342) 342
mice, inbred c57bl (341) 341
osteoclasts - physiology (341) 341
activation (338) 338
immunohistochemistry (338) 338
research article (336) 336
rheumatoid-arthritis (336) 336
bone mineral density (333) 333
bone-mineral density (333) 333
atherosclerosis (325) 325
case-control studies (325) 325
aged, 80 and over (323) 323
gene-expression (321) 321
cell differentiation - drug effects (320) 320
article (319) 319
medicine (315) 315
bone remodeling (314) 314
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6309) 6309
Chinese (162) 162
Japanese (34) 34
Polish (27) 27
German (21) 21
Korean (21) 21
French (16) 16
Russian (16) 16
Spanish (10) 10
Portuguese (5) 5
Italian (3) 3
Czech (2) 2
Croatian (1) 1
Dutch (1) 1
Indonesian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Periodontology, ISSN 0303-6979, 03/2012, Volume 39, Issue 3, pp. 239 - 248
Background and Objectives The receptor activator of NF‐κB ligand‐osteoprotegerin (RANKL‐OPG) bi‐molecular system is the “bottle‐neck” regulator of... 
gingival crevicular fluid | receptor activator of NF‐κB ligand | diagnostics | receptor activator of NF‐κB ligand/osteoprotegerin ratio | osteoprotegerin | periodontal disease | receptor activator of NF-ÎB ligand/osteoprotegerin ratio | receptor activator of NF-ÎB ligand | receptor activator of NF-?B ligand | DIFFERENTIAL EXPRESSION | osteoprotegerin ratio | NECROSIS-FACTOR-ALPHA | TRANSCRIPTION FACTOR NFATC1 | MESSENGER-RNA | DENTISTRY, ORAL SURGERY & MEDICINE | OSTEOPROTEGERIN LIGAND | RECEPTOR ACTIVATOR | OSTEOCLAST DIFFERENTIATION | KAPPA-B LIGAND | ALVEOLAR BONE DESTRUCTION | Alveolar Bone Loss - metabolism | Biomarkers - metabolism | Lymphocytes - metabolism | Alveolar Bone Loss - therapy | RANK Ligand - metabolism | Humans | Periodontitis - therapy | Diabetes Mellitus - metabolism | Periodontitis - blood | Gingival Crevicular Fluid - chemistry | Biomarkers - blood | Saliva - chemistry | Periodontal Ligament - metabolism | Periodontitis - metabolism | Dental Plaque - microbiology | Smoking - metabolism | RANK Ligand - blood | Animals | Gingiva - chemistry | Osteoporosis - metabolism | Osteoprotegerin - blood | Osteoprotegerin - metabolism | Osteoblasts - metabolism | Alveolar Bone Loss - blood | Oral hygiene | Immune system | Diabetes mellitus | biomarkers | Blood | Osteoprotegerin | Bone resorption | Osteoclastogenesis | Periodontal diseases | NF- Kappa B protein | Molecular modelling | Periodontitis | Gingiva | TRANCE protein | Saliva | Smoking
Journal Article
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 2014, Volume 5, p. 511
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2015, Volume 30, Issue 9, pp. 1627 - 1640
ABSTRACT Osteonecrosis of the jaws (ONJ) is a significant complication of antiresorptive medications, such as bisphosphonates and denosumab. Antiresorptive... 
ZOLEDRONIC ACID | ALVEOLAR BONE | BISPHOSPHONATES | OSTEOCLASTS | DENOSUMAB | OSTEONECROSIS OF THE JAW (ONJ) | ANTIRESORPTIVES | alveolar bone | antiresorptives | zoledronic acid | osteoclasts | bisphosphonates | denosumab | osteonecrosis of the jaw (ONJ) | RISK-FACTORS | INDUCE OSTEONECROSIS | NITROGEN-CONTAINING BISPHOSPHONATES | BONE-RESORPTION | POSTMENOPAUSAL OSTEOPOROSIS | CANCER-PATIENTS | CLINICAL-APPLICATIONS | BISPHOSPHONATE-RELATED OSTEONECROSIS | ENDOCRINOLOGY & METABOLISM | EXPERIMENTAL PERIODONTITIS | KAPPA-B LIGAND | RANK Ligand - metabolism | Recombinant Fusion Proteins - pharmacology | Tartrate-Resistant Acid Phosphatase | Male | Mandible - diagnostic imaging | X-Ray Microtomography | Acid Phosphatase - metabolism | Isoenzymes - metabolism | Diphosphonates - therapeutic use | Disease Models, Animal | Bone Resorption | Maxilla - diagnostic imaging | Mice, Inbred C57BL | Osteoprotegerin - pharmacology | Abscess | Rats | Imidazoles - pharmacology | Osteoclasts - metabolism | Animals | RANK Ligand - antagonists & inhibitors | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Immunoglobulin Fc Fragments - pharmacology | Mice | Denosumab - pharmacology | Bisphosphonate-Associated Osteonecrosis of the Jaw - drug therapy | Diphosphonates - pharmacology | Osteoporosis | Bones | Phosphonates | Necrosis | Animal models | Zoledronic acid | Mandibles | Osteonecrosis | Acid phosphatase (tartrate-resistant) | TRANCE protein | Acid phosphatase | Bisphosphonates | Osteoprotegerin | Metastases
Journal Article
Acta Reumatologica Portuguesa, ISSN 0303-464X, 07/2011, Volume 36, Issue 3, pp. 209 - 218
Journal Article